Anti-Psychotic drugs for the Elderly 2011

Elderly lady being given meds

When I was in my early ’20’s, I worked for a Mom and Pop nursing home. One of my jobs was to dispense medication to the 13 residents I took care of all by myself every weekend. They were all comatose, but at the time, I thought that was just the way “old” people were. The owners had told me that I needed to double the dosage for one resident because she had a tendency to try and run away. Every Friday night, I would arrive at the home at 8 p.m. All the residents were asleep. On Saturday, Sunday, and Monday morning, I would get up at 6 a.m. and start breakfast. At seven, I would get the residents up. I would help those residents who needed help with dressing. Then I would serve them their breakfast and their meds (except for Monday, because my job ended at 8 am.) I suppose there were other interactions with the residents throughout the day, but I don’t really remember what they were. Mostly, I prepared three meals and gave meds. I do not remember visitors coming. In fact, probably quite typical of a young person in their ’20’s, I did not do much more than I had been hired to do and lacked the curiosity to find out more of either my employees or the people for whom I was responsible. I had other interests and this job provided me the money and freedom to pursue my other interests.

Looking back on this time, I realize now that these individuals were comatose because of the “meds” I fed them throughout the day. The fact that I had no nursing experience, no CNA training, no gerontological training was not even a consideration when the owners of this home hired me. I was clearly a responsible person that they could entrust with what they asked me to do. Of course, all of this occurred pre-Nursing Home Reform Act of 1987. Once the Reform Act was made law, everything changed in nursing homes, right? Not!

This past month, I was involved in a discussion on a Linkedin sugroup called Elder Care Matters. The topic of discussion was the extensive use of antipsychotic drugs with our elderly.  One member attended a lecture in which she learned that 80 million seniors are on antipsychotic drugs. This number is staggering.

According to an article in the American Psychological Association, there is wide abuse of antipsychotic drugs in nursing homes. Plus ca change, plus c’est la meme chose!

  • 14 percent of the 2.1 million elderly people living in nursing homes use Medicare to pay for at least one antipsychotic prescription.
  • 83 percent of all Medicare claims for antipsychotics are, based on medical reviews, prescribed for off-label conditions, specifically dementia.
  • 22 percent of the claims for antipsychotics do not comply with the Centers for Medicare and Medicaid Services’ guidelines outlining how drugs should be administered, including those guidelines stating that nursing home residents should not receive excessive doses and doses over excessive periods of time.

The professionals in the field who are participating in these discussions all seem to agree that antipsychotic drugs have more detrimental side effects than benefits and that there are many alternative steps available that can and should be used before prescribing antipsychotic drugs.  I agree that engaging folks in activities they find rewarding and keeping them active during the day is ALWAYS the first step. In particular, allowing patients to do those things in daily life that they are used to doing and/or enjoy and find rewarding.

So why are antipsychotic drugs being used rather than alternative forms of therapy?   Unfortunately, this reflects the influence that pharmaceuticals have in the society at large and in our lives.  Quoting from the above mentioned article:

HHS Inspector General Daniel Levinson argued in the report that pharmaceutical companies’ marketing tactics are often to blame for antipsychotics’ overprescribing.

Also, pharmaceuticals and research are big business. CNAs or Occupational Therapists working one-on-one with residents is not.

Further, popping pills as a means of therapy reflects the nation we have become of the fast foods, the fast pace of life, and the quick fix.  It is much easier to pop a pill in somebody’s mouth than to spend an hour stimulating them with social activities. This is particularly true because there are not enough professionals in the field to provide alternative stimulation.

Again, from the American Psychological Association article:

Victor Molinari, PhD, a geropsychologist at the University of South Florida in Tampa, says that another important issue is the dearth of psychologists trained to provide behavioral interventions to people in nursing homes. While he agrees that people in nursing homes are taking too much antipsychotic medication, he believes nursing home physicians are often responding to a lack of options.

With boomers just entering the 65+ age group, we need to seriously re-evaluate the effectiveness of pharmaceutical drug use. Unfortunately, the alternative, having enough practitioners trained to interact with seniors, does not seem to be an available option.

Med students tend not to go into the geriatric field (the return on investment is much less than work in specialty fields such as dermatology, plastic surgery, otolaryngology, radiation oncology, to name a few).

Irene Teesdale CLC, a Gerontologist from North Carolina, one of the participants in this linked in “conversation”, shared the following stats:

A career focused on caring for older adults can be particularly financially unattractive for physicians with increasingly large medical school loan debts. Physicians graduating from U.S. medical schools in 2010 owed an average of $158,996 for their education. Thirty-nine percent of these graduates said that salary expectations were a moderate or strong influence in determining their specialty.

In many parts of the U.S.,

Medicare payment rates for physicians are lower than commercial insurance rates. Medicare reimbursement rates for mental health services are discounted even further than rates for geriatric medical services. Medicare reimbursement is the major source of income for most geriatricians and, as a result, community-based geriatricians have lower incomes than most other physician specialists.

Only a small proportion of practicing healthcare providers have formal training in geriatrics, with less than 1% of doctors, dentists, pharmacists, and nurses, and only 5% of social workers having certification or advanced training in geriatrics or gerontology.

We need to push our representatives to allow the geriatric field to become more accessible and attractive to students entering the medical field.  Subsidies for education in the field may be one way to do this.  More reward out in the field after graduation through larger payouts from Medicare and secondary insurances may also help.

Although dementia does strike older individuals as a “side effect” of aging, there is more and more acknowledgement that a lot of dementia like symptoms are caused by the interactions of drugs.

(more in my next blog)

© Yvonne Behrens, M.Ed  2011



$20 Billion Industry

Diagram of how microtubules desintegrate with ...

disintegrated microtubules

An August weekend copy of the Europe The Wall Street Journal carried an article entitled: “Research Points to ‘Silent Phase’ of Alzheimer’s.” The first paragraph stated that a new “explosion” of research has been bolstering “an emerging view” that Alzheimer’s disease can begin to ravage “the brain years or even decades before” enough symptoms appear to diagnose the disease.

These findings, presented at the Alzheimer’s Association International Conference, are apparently influencing how scientists are thinking about the disease “…and the pharmaceutical industry’s quest for effective drugs against the disease.”

The article continued: “The findings are prompting companies like Pfizer Inc., Johnson & Johnson and Bristol-Myers Squibb Col to increase their focus on patients with mild memory symptoms.”

The next paragraph contained a sentence, which was the one for why I share this information with you: “Some analysts estimate the market for a drug that could slow or reverse Alzheimer’s could be as large as $20 billion a year.“

I hold the personal belief that the Alzheimer’s Association (not the Alzheimer’s Foundation or other organizations that have been formed to fight Alzheimer’s) is using marketing to make mucho buckos.  Their aggressive marketing has succeeded in making people believe that Alzheimer’s is the only form of dementia out there.  Dementia is no longer the umbrella term for loss of memory and every day functions.  Alzheimer’s is.

Certainly there should be a concern with regard to Alzheimer’s disease.  But it really is not the only form of dementia out there.  Below are a few other causes of dementia and this list by no means cover all the causes:

  • Vascular dementia
  • Parkinson’s disease
  • Dementia with Lewy bodies
  • Huntington’s disease
  • Alcohol related dementia – Korsakoff’s syndrome
  • AIDS related dementia
  • Fronto Temporal Lobar Degeneration (FTLD)
  • Creutzfeldt-Jakob disease.

An article that speaks about findings that “may indicate” that the “ravages” of Alzheimer’s “may occur before symptoms do” seems to reflect more the rather aggressive means by which the Alzheimer’s Association is trying to corner the market than anything that could potentially alter the onset of Alzheimer’s.  But the Association does have the public’s attention and apparently the pharmaceutical Industry’s attention as well.  One could endlessly produce pills that might counter what might be the beginning stages of Alzheimer’s.  Whether these pills are successful or not seem, if one were to read the article as written [granted, for the Wall Street Journal], secondary to the fact that this endeavor could potentially be a $20 billion industry.


Enhanced by Zemanta